HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 32 adverse event reports in the FDA FAERS database where HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN was used for Off label use.
Most Reported Side Effects for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Sinusitis | 436 | 10.0% | 6 | 55 |
| Headache | 375 | 8.6% | 6 | 76 |
| Fatigue | 336 | 7.7% | 12 | 71 |
| Malaise | 259 | 5.9% | 19 | 77 |
| Pneumonia | 259 | 5.9% | 35 | 133 |
| Pyrexia | 249 | 5.7% | 23 | 88 |
| Death | 231 | 5.3% | 230 | 60 |
| Infusion site pain | 230 | 5.3% | 6 | 26 |
| Nausea | 223 | 5.1% | 9 | 54 |
| Covid-19 | 215 | 4.9% | 58 | 103 |
| Infusion site erythema | 213 | 4.9% | 8 | 26 |
| Pain | 200 | 4.6% | 9 | 48 |
| Infusion site swelling | 194 | 4.4% | 5 | 25 |
| Infusion site extravasation | 185 | 4.2% | 5 | 30 |
| Nasopharyngitis | 176 | 4.0% | 3 | 23 |
Other Indications for HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN
Immunodeficiency common variable (1,598)
Primary immunodeficiency syndrome (1,055)
Product used for unknown indication (1,006)
Immunodeficiency (224)
Hypogammaglobulinaemia (162)
Selective igg subclass deficiency (136)
Secondary immunodeficiency (127)
Chronic lymphocytic leukaemia (35)
Immune system disorder (35)
Congenital hypogammaglobulinaemia (31)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)